Keyphrases
Scotland
100%
People Who Inject Drugs
62%
Opioid Agonist Treatment
46%
Retrospective Cohort Study
36%
Prescribed Opioids
33%
Hepatitis C
31%
Direct-acting Antivirals
30%
Cirrhosis
22%
Hepatocellular Carcinoma
21%
Confidence Interval
21%
Hepatitis C Virus
20%
Drug-related Deaths
19%
HIV Pre-exposure Prophylaxis
14%
Newly Diagnosed
14%
Take-home Naloxone
14%
Pre-exposure Prophylaxis (PrEP)
14%
Population Prevalence
14%
Vaccine Uptake
14%
Population-based Cohort Study
14%
COVID-19
14%
Opioid Dependence
13%
Glasgow
13%
HIV Testing
13%
Interferon-free
10%
Direct-acting Antiviral Treatment
10%
Novel Psychoactive Substances
10%
Population Level
9%
Prison
9%
Drug Services
9%
Drug Dependence
9%
Tayside
9%
Prevalence Estimation
8%
Population Impact
8%
Mortality Rate
8%
Decompensated Cirrhosis
8%
Hepatitis C Virus Infection
8%
Hospital Admission
8%
Hepatocellular Carcinoma Risk
8%
Prognostic Model
8%
Sustained Viral Response
8%
Direct-acting Antiviral Therapy
7%
Prevalence Study
7%
Viremia
7%
Blood-borne Viruses
7%
Hepatitis C Virus Prevalence
7%
Vaccination
7%
Scottish
7%
Rapid Rise
7%
HIV Testing Uptake
7%
Series Analysis
7%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
39%
Antivirus Agent
38%
Hepatitis C
36%
Cohort Study
35%
Opiate Agonist
33%
Prevalence
30%
Liver Cell Carcinoma
21%
Hepatitis C Virus
20%
Liver Cirrhosis
16%
Interferon
16%
Antiviral Therapy
15%
Hepatitis B
14%
Disease
14%
Opiate Addiction
13%
Mortality Rate
8%
Viremia
7%
Reinfection
7%
Z-Drug
7%
Decompensated Liver Cirrhosis
7%
Gabapentinoid
7%
COVID-19 Vaccine
7%
Naloxone
7%
HIV
7%
Infectious Agent
7%
Disease Transmission
7%
SARS Coronavirus
7%
Medicine and Dentistry
Infection
40%
Hepatitis C
31%
Hepatocellular Carcinoma
28%
Liver Cirrhosis
23%
Antiviral Therapy
22%
Prevalence
22%
Human Immunodeficiency Virus
21%
Hepatitis C Virus
20%
Interferon
16%
Retrospective Cohort Study
15%
Cohort Analysis
14%
Hepatitis B
14%
Opiate Agonist
13%
Antivirus Agent
13%
Population
11%
Gene Linkage
9%
Mortality Rate
8%
Time Series Analysis
7%
Opioid Dependence
7%
Pre-Exposure Prophylaxis
7%
Naloxone
7%
COVID-19
7%
Viremia
7%
Risk Communication
7%
Clinical Decision Making
7%
Decompensated Liver Cirrhosis
7%
HIV Test
7%
Stakeholder Engagement
7%
Horizontal Disease Transmission
7%
Reassurance
7%